Latest News About Glyphosate-Based Herbicides

Here are the latest publicly reported developments on glyphosate-based herbicides as of May 2026:

Brief take

• There is ongoing scrutiny of glyphosate safety, with renewed attention to regulatory reviews and court cases in several countries. Regulators in some jurisdictions face pressure to reassess carcinogenic potential and environmental impacts in light of new and retracted studies, while others reaffirm current safety assessments pending additional data.[1][4]

Key recent themes

• Scientific integrity concerns and retractions: A landmark long-running study on glyphosate safety faced retraction guidance due to undisclosed involvement by a sponsor, triggering calls for independent re-evaluation of evidence and precautionary reviews by health authorities.[4][1]
• Regulatory reviews and risk assessments: Several sources indicate that agencies in North America and Europe are being urged to revisit glyphosate’s regulatory status, including environmental risk assessments and potential carcinogenicity debates, amid ongoing litigation and evolving scientific findings.[2][3]
• Industry responses and market implications: Manufacturers and some industry voices continue to defend glyphosate’s safety profiles, while other reports mention possible shifts in corporate strategy or legal risk management related to Roundup and its successors amid legal settlements and pressures from activist groups.[5][2]
• Public health and consumer guidance: Health agencies in various countries have reiterated that current exposure levels among the general population remain within assessed safety margins, though independent scientists and advocacy groups urge more precautionary reviews, particularly regarding vulnerable populations and cumulative exposure.[6][4]

Representative items you may find relevant

• High-profile coverage of a retraction related to glyphosate safety data and subsequent calls for EPA/regulatory re-evaluation in the United States as well as parallel scrutiny in other countries.[1]
• Reports about the EPA and other regulators delaying or revisiting interim conclusions on glyphosate risk as new analyses and lawsuits unfold.[2]
• Discussions around potential shifts in glyphosate production or reliance on legal settlements impacting Bayer/Monsanto’s strategic stance in the U.S. and abroad.[5][2]

Notes and caveats

• The landscape on glyphosate is highly dynamic, with regulatory decisions, court cases, and science coming from multiple jurisdictions. If you’d like, I can narrow this to a specific region (e.g., UK/Europe, Canada, or the U.S.), or focus on a particular aspect (regulatory status, health studies, or court developments) and provide a tight, up-to-date briefing with direct citations.
• If you want a quick, visual update (timeline of key events or a chart of regulatory decisions by country), tell me and I’ll prepare a concise graphic with sources.

Would you like a region-specific briefing or a short timeline of the last 12–18 months with citations?